78P Final analysis of the French real-world study EVIDENS: Effectiveness, safety & quality of life at 36 months of nivolumab in advanced non-small cell lung cancer (NSCLC)
| Autor: | Barlesi, F., Dixmier, A., Debieuvre, D., Raspaud, C., Auliac, J.B., Benoit, N., Bombaron, P., Moro-Sibilot, D., Asselain, B., Audigier-Valette, C., Brellier, F., Cotté, F-E., Pérol, M. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2023 20 Supplement |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|